Difficulty: Medium
Average Score: 83%
Practice
What is the purpose of amniocentesis for a patient hospitalized at 34 weeks of gestation with pregnancy-induced hypertension?
Correct answer
D
Rationale
Amniocentesis is a procedure where amniotic fluid is extracted from the amniotic sac surrounding the fetus. In the context of a patient hospitalized at 34 weeks of gestation with pregnancy-induced hypertension, the primary purpose of amniocentesis would be to determine fetal lung maturity. This information is crucial in deciding whether early delivery is necessary to prevent complications associated with prematurity.
Option A, determining if a metabolic disorder exists, is not the primary reason for performing amniocentesis in this scenario. Metabolic disorders are typically assessed through genetic testing or other diagnostic procedures rather than amniocentesis.
Option B, identifying the sex of the fetus, is not a valid reason for performing amniocentesis at 34 weeks of gestation in a patient with pregnancy-induced hypertension. The sex of the fetus does not impact the management of the pregnancy in this case.
Option C, identifying abnormal fetal cells, is also not the primary purpose of amniocentesis in this context. While amniocentesis can detect genetic abnormalities, the immediate concern in a patient with pregnancy-induced hypertension at 34 weeks would be assessing fetal lung maturity to guide clinical decision-making.
Educationally, understanding the rationale behind the use of specific diagnostic procedures like amniocentesis in different clinical scenarios is crucial for healthcare providers involved in the care of pregnant women. It highlights the importance of timely and accurate assessments to ensure optimal outcomes for both the mother and the fetus.
Option A, determining if a metabolic disorder exists, is not the primary reason for performing amniocentesis in this scenario. Metabolic disorders are typically assessed through genetic testing or other diagnostic procedures rather than amniocentesis.
Option B, identifying the sex of the fetus, is not a valid reason for performing amniocentesis at 34 weeks of gestation in a patient with pregnancy-induced hypertension. The sex of the fetus does not impact the management of the pregnancy in this case.
Option C, identifying abnormal fetal cells, is also not the primary purpose of amniocentesis in this context. While amniocentesis can detect genetic abnormalities, the immediate concern in a patient with pregnancy-induced hypertension at 34 weeks would be assessing fetal lung maturity to guide clinical decision-making.
Educationally, understanding the rationale behind the use of specific diagnostic procedures like amniocentesis in different clinical scenarios is crucial for healthcare providers involved in the care of pregnant women. It highlights the importance of timely and accurate assessments to ensure optimal outcomes for both the mother and the fetus.